Literature DB >> 6304329

Diltiazem and verapamil preferentially block inactivated cardiac calcium channels.

S Kanaya, P Arlock, B G Katzung, L M Hondeghem.   

Abstract

Diltiazem has been proposed to act by blocking calcium channels of cardiac and smooth muscle since it has pharmacological [12-14] and clinical [10] effects that resemble those of verapamil, an agent that has been shown to block these channels [3]. However, block of the slow inward current by diltiazem has not been directly demonstrated. In fact, it has been suggested that diltiazem has an entirely different mechanism of action [7]. We therefore studied the blocking effects of diltiazem and verapamil on cardiac calcium channels by measuring the slow inward current in voltage-clamped ferret myocardium. Both drugs blocked the slow inward current in a use-dependent fashion, i.e. the block was enhanced by increased frequency of activating clamps and by more positive holding potentials. However, we found that short single activating clamps resulted in minimal block, whereas prolonging the clamp step progressively enhanced the blockade. Thus, a single long clamp caused as much blockade as a train of shorter pulses. These results demonstrate that diltiazem and verapamil block the slow inward current by binding to calcium channels in a state-dependent fashion, i.e. inactivated channels have a high affinity for the drugs, while rested and open channels have a lower affinity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304329     DOI: 10.1016/0022-2828(83)90291-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

1.  Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.

Authors:  H Nakaya; Y Hattori; N Tohse; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

2.  Calcium channel antagonists: pharmacological considerations.

Authors:  D Rampe; C M Su; F Yousif; D J Triggle
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  Nimodipine block of calcium channels in rat anterior pituitary cells.

Authors:  C J Cohen; R T McCarthy
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

Review 4.  Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

5.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

6.  Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.

Authors:  M J Robertson; P Lumley
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit.

Authors:  L Ustünes; M Yasa; Z Kerry; N Ozdemir; T Berkan; Y Erhan; A Ozer
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  The effect of the benzothiazepine diltiazem on force and Ca2+ current in isolated frog skeletal muscle fibres.

Authors:  T Böhle
Journal:  J Physiol       Date:  1992-01       Impact factor: 5.182

9.  Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells.

Authors:  A Uehara; J R Hume
Journal:  J Gen Physiol       Date:  1985-05       Impact factor: 4.086

10.  Solanaceae glycoalkaloids: α-solanine and α-chaconine modify the cardioinhibitory activity of verapamil.

Authors:  Szymon Chowański; Magdalena Winkiel; Monika Szymczak-Cendlak; Paweł Marciniak; Dominika Mańczak; Karolina Walkowiak-Nowicka; Marta Spochacz; Sabino A Bufo; Laura Scrano; Zbigniew Adamski
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.